Company Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments.
It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services.
The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets.
Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
| Country | United States |
| Founded | 1943 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 14,500 |
| CEO | Liam Kelly |
Contact Details
Address: 550 East Swedesford Road, Suite 400 Wayne, Pennsylvania 19087-1603 United States | |
| Phone | 610-225-6800 |
| Website | teleflex.com |
Stock Details
| Ticker Symbol | TFX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000096943 |
| CUSIP Number | 879369106 |
| ISIN Number | US8793691069 |
| Employer ID | 23-1147939 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Liam J. Kelly | Chairman, President and Chief Executive Officer |
| Thomas E. Powell BS, MBA | Executive Vice President and Chief Financial Officer |
| Jay White | Corporate Vice President and President of Global Commercial |
| John R. Deren | Corporate Vice President and Chief Accounting Officer |
| Timothy F. Duffy | Vice President and Chief Information Officer |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer |
| Cameron P. Hicks | Corporate Vice President and Chief Human Resources Officer |
| James Ferguson | President and GM of Surgical |
| Michelle Fox | Corporate Vice President and Chief Medical Officer |
| Matthew James | President, EMEA and Global Urology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 31, 2024 | 10-Q | Quarterly Report |
| Oct 31, 2024 | 8-K | Current Report |
| Aug 29, 2024 | 8-K | Current Report |
| Aug 16, 2024 | 144 | Filing |
| Aug 5, 2024 | 8-K | Current Report |
| Aug 2, 2024 | 10-Q | Quarterly Report |